Identification of an independent immune-genes prognostic index for renal cell carcinoma

被引:3
|
作者
Li, Guangyao [1 ]
Wei, Xiyi [1 ]
Su, Shifeng [1 ]
Wang, Shangqian [1 ]
Wang, Wei [1 ]
Wang, Yichun [1 ]
Meng, Xianghu [1 ]
Xia, Jiadong [1 ]
Song, Ninghong [1 ,2 ]
Qin, Chao [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing 210029, Peoples R China
[2] Nanjing Med Univ, Affiliated Kezhou Peoples Hosp, Kezhou 845350, Xinjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Immune-related genes; Clear cell renal cell carcinoma; Prognosis; Nomogram; Immune risk score model; INFLAMMATION; PROGRESSION; METASTASIS; RESISTANCE; KIDNEY;
D O I
10.1186/s12885-021-08367-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Considerable evidence has indicated an association between the immune microenvironment and clinical outcome in ccRCC. The purpose of this study is to extensively figure out the influence of immune-related genes of tumors on the prognosis of patients with ccRCC. Methods Files containing 2498 immune-related genes were obtained from the Immunology Database and Analysis Portal (ImmPort), and the transcriptome data and clinical information relevant to patients with ccRCC were identified and downloaded from the TCGA data-base. Univariate and multivariate Cox regression analyses were used to screen out prognostic immune genes. The immune risk score model was established in light of the regression coefficient between survival and hub immune-related genes. We eventually set up a nomogram for the prediction of the overall survival for ccRCC. Kaplan-Meier (K-M) and ROC curve was used in evaluating the value of the predictive risk model. A P value of < 0.05 indicated statistically significant differences throughout data analysis. Results Via differential analysis, we found that 556 immune-related genes were expressed differentially between tumor and normal tissues (p < 0. 05). The analysis of univariate Cox regression exhibited that there was a statistical correlation between 43 immune genes and survival risk in patients with ccRCC (p < 0.05). Through Lasso-Cox regression analysis, we established an immune genetic risk scoring model based on 18 immune-related genes. The high-risk group showed a bad prognosis in K-M analysis. (p < 0.001). ROC curve showed that it was reliable of the immune risk score model to predict survival risk (5 year over survival, AUC = 0.802). The model indicated satisfactory AUC and survival correlation in the validation data set (5 year OS, Area Under Curve = 0.705, p < 0.05). From Multivariate regression analysis, the immune-risk score model plays an isolated role in the prediction of the prognosis of ccRCC. Under multivariate-Cox regression analysis, we set up a nomogram for comprehensive prediction of ccRCC patients' survival rate. At last, it was identified that 18 immune-related genes and risk scores were not only tremendously related to clinical prognosis but also contained in a variety of carcinogenic pathways. Conclusion In general, tumor immune-related genes play essential roles in ccRCC development and progression. Our research established an unequal 18-immune gene risk index to predict the prognosis of ccRCC visually. This index was found to be an independent predictive factor for ccRCC.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Identification of Immune-Related Cells and Genes in Tumor Microenvironment of Clear Cell Renal Cell Carcinoma
    Du, Bowen
    Zhou, Yulin
    Yi, Xiaoming
    Zhao, Tangliang
    Tang, Chaopeng
    Shen, Tianyi
    Zhou, Kai
    Wei, Huixian
    Xu, Song
    Dong, Jie
    Qu, Le
    He, Haowei
    Zhou, Wenquan
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [42] Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis
    Wu, Hongwei
    Fan, Lijing
    Liu, Haiping
    Guan, Baozhang
    Hu, Bo
    Liu, Fanna
    Hocher, Berthold
    Yin, Lianghong
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [43] Immune Cell Infiltration and Identifying Genes of Prognostic Value in the Papillary Renal Cell Carcinoma Microenvironment by Bioinformatics Analysis
    Liu, Ting
    Zhang, Man
    Sun, Deming
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [44] Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
    Hua, Shan
    Xie, Zhiwen
    Zhang, Yongqing
    Wu, Lei
    Shi, Fei
    Wang, Xingjie
    Xia, Shujie
    Dong, Shengli
    Jiang, Juntao
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Identification of novel prognostic biomarkers in renal cell carcinoma
    Zou, Yuanzhang
    Lu, Qiu
    Yao, Qin
    Dong, Di
    Chen, Binghai
    AGING-US, 2020, 12 (24): : 25304 - 25318
  • [46] Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
    U M Vogl
    H Zehetgruber
    M Dominkus
    M Hejna
    C C Zielinski
    A Haitel
    M Schmidinger
    British Journal of Cancer, 2006, 95 : 691 - 698
  • [47] Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
    Vogl, U. M.
    Zehetgruber, H.
    Dominkus, M.
    Hejna, M.
    Zielinski, C. C.
    Haitel, A.
    Schmidinger, M.
    BRITISH JOURNAL OF CANCER, 2006, 95 (06) : 691 - 698
  • [48] Prognostic value of systemic immune-inflammation index in patients with locally advanced renal cell carcinoma
    Lin, Tsu-Chen
    Su, Shih-Huan
    Huang, Wen-Kuan
    Chen, Dong-Yi
    Pang, See-Tong
    Chuang, Cheng-Keng
    UROLOGICAL SCIENCE, 2024, 35 (03) : 121 - 126
  • [49] A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes
    Peng Cao
    Ji-Yue Wu
    Jian-Dong Zhang
    Ze-Jia Sun
    Xiang Zheng
    Bao-Zhong Yu
    Hao-Yuan Cao
    Fei-Long Zhang
    Zi-Hao Gao
    Wei Wang
    BMC Cancer, 22
  • [50] A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes
    Cao, Peng
    Wu, Ji-Yue
    Zhang, Jian-Dong
    Sun, Ze-Jia
    Zheng, Xiang
    Yu, Bao-Zhong
    Cao, Hao-Yuan
    Zhang, Fei-Long
    Gao, Zi-Hao
    Wang, Wei
    BMC CANCER, 2022, 22 (01)